Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Richman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Plos One|May 22, 2020
Defining gentrification for epidemiologic research: A systematic reviewNrupen A Bhavsar, Manish Kumar, Laura Richman
SSM - Population Health|April 24, 2019
Addressing health inequalities in diverse, rural communities: An unmet needLaura Richman, Jay Pearson, Cherry Beasley, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 12, 2007
Why do people with an anxiety disorder utilize more nonmental health care than those without?Andrea Gurmankin Levy, Joanna Maselko, Mark Bauer, et al.
Vaccine|December 1, 2009
Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine productionJonathan Liu, Sachin Mani, Richard Schwartz, et al.
Arthritis Research & Therapy|April 16, 2010
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosusYihong Yao, Brandon W Higgs, Laura Richman, et al.
Journal of Biopharmaceutical Statistics|October 31, 2014
Non-normal random effects models for immunogenicity assay cut point determinationJianchun Zhang, Binbing Yu, Lanju Zhang, et al.
Journal of the National Medical Association|December 15, 2010
The association of optimism and perceived discrimination with health care utilization in adults with sickle cell diseaseMichael V Stanton, Charles R Jonassaint, Frederick B Bartholomew, et al.
International Journal of Rheumatic Diseases|February 14, 2012
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patientsBrandon W Higgs, Wei Zhu, Laura Richman, et al.
Molecular Therapy. Methods & Clinical Development|May 19, 2020
Translational Feasibility of Lumbar Puncture for Intrathecal AAV AdministrationChristian Hinderer, Nathan Katz, Cecilia Dyer, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Plos One|May 22, 2020
Defining gentrification for epidemiologic research: A systematic reviewNrupen A Bhavsar, Manish Kumar, Laura Richman
SSM - Population Health|April 24, 2019
Addressing health inequalities in diverse, rural communities: An unmet needLaura Richman, Jay Pearson, Cherry Beasley, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 12, 2007
Why do people with an anxiety disorder utilize more nonmental health care than those without?Andrea Gurmankin Levy, Joanna Maselko, Mark Bauer, et al.
Vaccine|December 1, 2009
Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine productionJonathan Liu, Sachin Mani, Richard Schwartz, et al.
Arthritis Research & Therapy|April 16, 2010
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosusYihong Yao, Brandon W Higgs, Laura Richman, et al.
Journal of Biopharmaceutical Statistics|October 31, 2014
Non-normal random effects models for immunogenicity assay cut point determinationJianchun Zhang, Binbing Yu, Lanju Zhang, et al.
Journal of the National Medical Association|December 15, 2010
The association of optimism and perceived discrimination with health care utilization in adults with sickle cell diseaseMichael V Stanton, Charles R Jonassaint, Frederick B Bartholomew, et al.
International Journal of Rheumatic Diseases|February 14, 2012
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patientsBrandon W Higgs, Wei Zhu, Laura Richman, et al.
Molecular Therapy. Methods & Clinical Development|May 19, 2020
Translational Feasibility of Lumbar Puncture for Intrathecal AAV AdministrationChristian Hinderer, Nathan Katz, Cecilia Dyer, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
Pageof 3